Ucwaningo lukhombisa ukuthi i-PixCell's HemoScreen™ ingasetshenziswa ukuqapha amasampula egazi le-pathological kanye nokwenza ngcono inqubo yokwelashwa kweziguli ezinezifo zegazi.
ILIT, York, Israel, Okthoba 13, 2020 /PRNewswire/ - I-PixCell Medical, umsunguli wezixazululo zokuxilonga eziseduze kombhede, namuhla umemezele imiphumela yocwaningo olusha olushicilelwe ku-International Journal of Laboratory Hematology Ngenxa yalokho, ucwaningo lukhombisa ukuthi I-HemoScreen™ yokuhlaziya igazi eliseceleni kombhede yenkampani ifanele ukuhlolwa nokuphathwa kweziguli ezinomdlavuza wegazi ezelashwa ngamakhemikhali.
Abacwaningi baseSibhedlela saseNyakatho New Zealand, iNyuvesi yaseCopenhagen, iBispebjerg neFrederiksberg Hospital e-Copenhagen, kanye neNyuvesi yaseSouthern Denmark baqhathanise i-HemoScreen™ kanye ne-Sysmex XN-9000 kumasampula emithanjeni angu-206 kanye ne-79 white blood cell (WBC) eceleni kombhede we-capillary. amasampula , Isibalo esiphelele se-neutrophil (ANC), amangqamuzana egazi abomvu (RBC), isibalo seplatelet (PLT) ne-hemoglobin (HGB).
“Iziguli ezinomdlavuza ezilashwa ngamakhemikhali anamandla zivame ukuhlushwa umnkantsha onzima ngenxa yokwelashwa futhi zidinga ukuqapha njalo isibalo segazi eliphelele (CBC),” kusho uDkt. Avishay Bransky, oyi-CEO ye-PixCell Medical.“Lolu cwaningo lubonisa ukuthi i-HemoScreen inganikeza imiphumela esheshayo nethembekile yamasampula avamile namasampula e-pathological.Ukusetshenziswa kabanzi kwalolu cingo kungase kuqede ukuvakashela ezibhedlela okungabalulekile futhi kunciphise kakhulu isikhathi sokubonisana esidingekayo—kulabo asebevele behlushwa ukugula nokukhathala.Ezigulini, lo wumdlalo oshintshayo.”
Idatha ibonisa ukuthi i-HemoScreen isebenzisa u-40 μl wegazi le-venous noma i-capillary kanye nokugxila okuphansi kwe-WBC, i-ANC, i-RBC, i-PLT ne-HGB ukuze inikeze imiphumela yokuhlola esheshayo nethembekile emtholampilo yokuqondisa ukumpontshelwa igazi kanye nokwelashwa kwangemva kokwelashwa ngamakhemikhali.Ithimba locwaningo liphinde lathola ukuthi i-HemoScreen izwela ngokwanele kulebula yamasampuli e-pathological kanye namaseli angavamile (okuhlanganisa amaseli egazi abomvu angama-nucleated, ama-granulocyte angavuthiwe, namaseli akudala), futhi yehlisa kakhulu isikhathi sokushintsha imiphumela yokuhlolwa.
I-HemoScreen™, ethuthukiswe yi-PixCell Medical, iyona kuphela ehlaziya i-hematology egunyazwe i-FDA, eyenzelwe i-point-of-care (POC), ehlanganisa i-flow cytometry nokuthwebula kwedijithali endaweni eyodwa.I-compact hematology analyzer ephathekayo ingaqedela ukuhlolwa kwegazi eliphelele (i-CBC) emizuzwini engu-6, futhi isebenzisa ikhithi elahlwayo egcwaliswe kusengaphambili nazo zonke izinto ezisebenza ngokunye ezidingekayo ukuze kuhlolwe ilabhorethri esheshayo, enembile futhi elula.
Ucwaningo luphethe ngokuthi i-HemoScreen ifaneleka kakhulu emitholampilo emincane yeziguli zangaphandle futhi ingase ifanelekele ukusetshenziswa ekhaya.
I-PixCell Medical ihlinzeka ngesixazululo sokuqala esiphathwa ngokushesha sokuxilonga igazi.Isebenzisa ubuchwepheshe bokugxila be-viscoelastic obunelungelo lobunikazi benkampani kanye nombono womshini wobuhlakani bokwenziwa, inkundla yokuxilonga ye-HemoScreen egunyazwe yi-PixCell futhi egunyazwe yi-CE inciphisa isikhathi sokulethwa kwemiphumela yokuxilonga sisuka ezinsukwini ezimbalwa siye emizuzwini embalwa.Ngethonsi nje legazi, i-PixCell inganikeza ukufundwa okunembile kwemingcele yesibalo segazi esivamile esingu-20 phakathi nemizuzu eyisithupha, konga iziguli, odokotela nezinhlelo zezempilo isikhathi esiningi nezindleko.
Isikhathi sokuthumela: Jul-15-2021